Their study demonstrated that HOXA5 expression is significantly associated with poor prognosis in uterine corpus endometrioid adenocarcinoma (p = 0.044; HR = 1.832) [16]. The gene discussed is HOXA5; the disease is endometrial endometrioid adenocarcinoma.